| pubmed-article:6316962 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6316962 | lifeskim:mentions | umls-concept:C0024660 | lld:lifeskim |
| pubmed-article:6316962 | lifeskim:mentions | umls-concept:C0034785 | lld:lifeskim |
| pubmed-article:6316962 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6316962 | lifeskim:mentions | umls-concept:C0376446 | lld:lifeskim |
| pubmed-article:6316962 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:6316962 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6316962 | pubmed:dateCreated | 1984-1-7 | lld:pubmed |
| pubmed-article:6316962 | pubmed:abstractText | Under reducing conditions (5% beta-mercaptoethanol) the mammalian beta-adrenergic receptor binding site from both beta 1 (porcine heart membranes) and beta 2 receptors (hamster lung and rat erythrocyte membranes) appears to reside on peptides of Mr 62,000-65,000 as determined by photoaffinity labeling with p-azido-m-[125I]iodobenzylcarazolol and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. When similar experiments are performed in these same systems under a variety of non-reducing conditions, there are minimal changes in the apparent molecular weight of both the beta 1- and beta 2-adrenergic receptor binding subunits and no specifically labeled higher molecular weight proteins are observed suggesting that there are no disulfide linked subunits in mammalian beta-adrenergic receptors. | lld:pubmed |
| pubmed-article:6316962 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6316962 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6316962 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6316962 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6316962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6316962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6316962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6316962 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6316962 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:6316962 | pubmed:issn | 0006-291X | lld:pubmed |
| pubmed-article:6316962 | pubmed:author | pubmed-author:StrasserR HRH | lld:pubmed |
| pubmed-article:6316962 | pubmed:author | pubmed-author:StilesG LGL | lld:pubmed |
| pubmed-article:6316962 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6316962 | pubmed:day | 31 | lld:pubmed |
| pubmed-article:6316962 | pubmed:volume | 116 | lld:pubmed |
| pubmed-article:6316962 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6316962 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6316962 | pubmed:pagination | 777-82 | lld:pubmed |
| pubmed-article:6316962 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:meshHeading | pubmed-meshheading:6316962-... | lld:pubmed |
| pubmed-article:6316962 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6316962 | pubmed:articleTitle | The effect of reducing agents on the structure of mammalian beta-adrenergic receptors. | lld:pubmed |
| pubmed-article:6316962 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6316962 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6316962 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
